by John Conrad | Nov 20, 2025 | Member News
Abbott confirmed a $21 billion deal to acquire Exact Sciences, instantly becoming one of the biggest moves in diagnostics in years. Abbott will pay $105 per share in cash, a 51% premium, sending Exact’s stock sharply higher for a second straight day. The deal gives...
by John Conrad | Nov 17, 2025 | iBIO News
Even with Washington hitting the pause button during the federal shutdown, this month’s GBG Report still surfaced 78 new non-dilutive funding opportunities, notices of special interest, and RFIs across the life sciences landscape. That’s a slimmer number than usual —...
by John Conrad | Nov 10, 2025 | iBIO News
The Illinois life sciences community gathered last Thursday evening at The Salt Shed’s Three Top Lounge for the 2025 iBIO iCON Awards. The event brought together researchers, CEOs, entrepreneurs, investors, policymakers, educators, and community partners for a night...
by John Conrad | Oct 28, 2025 | iBIO News
iBIO (Illinois Biotechnology Innovation Organization) is proud to announce the winners of the 2025 iCON Awards, recognizing extraordinary leaders who have driven innovation and growth within Illinois’s thriving life sciences community. Now in its 13th year, the...
by John Conrad | Oct 10, 2025 | Policy News
There’s been a lot of misinformation circulating about the 340B Drug Pricing Program and HB2371 in Illinois. Let’s separate fact from fiction. We’ve been hearing some wild claims from hospital lobbying groups about what will happen if HB2371 doesn’t pass....
